Glycolipids in Parkinson's disease: beyond neuronal function
FEBS Open Bio · 2023-09 · 13 (9) · 1558-1579
DOI: 10.1002/2211-5463.13651 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEBS Open Bio, online erschienen am 04.06.2023. Verfasst von Fokion Spanos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institut Imagine, INSERM UMR1163, Paris Cité University, France. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council, Michael J. Fox Foundation for Parkinson's Research.
Abstract (Originalsprache)
Glycolipid balance is key to normal body function, and its alteration can lead to a variety of diseases involving multiple organs and tissues. Glycolipid disturbances are also involved in Parkinson's disease (PD) pathogenesis and aging. Increasing evidence suggests that glycolipids affect cellular functions beyond the brain, including the peripheral immune system, intestinal barrier, and immunity. Hence, the interplay between aging, genetic predisposition, and environmental exposures could initiate systemic and local glycolipid changes that lead to inflammatory reactions and neuronal dysfunction. In this review, we discuss recent advances in the link between glycolipid metabolism and immune function and how these metabolic changes can exacerbate immunological contributions to neurodegenerative diseases, with a focus on PD. Further understanding of the cellular and molecular mechanisms that control glycolipid pathways and their impact on both peripheral tissues and the brain will help unravel how glycolipids shape immune and nervous system communication and the development of novel drugs to prevent PD and promote healthy aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Imagine, INSERM UMR1163, Paris Cité University, France.
- Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.
- Department of Neurodegenerative Diseases, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Germany.
ORCID-Profile: Fokion Spanos, Michela Deleidi
Förderung
- H2020 European Research Council
- Michael J. Fox Foundation for Parkinson's Research
Zitieren
APA
Spanos, F., & Deleidi, M. (2023). Glycolipids in Parkinson's disease: beyond neuronal function. FEBS Open Bio, 13(9), 1558-1579. https://doi.org/10.1002/2211-5463.13651
Vancouver
Spanos F, Deleidi M. Glycolipids in Parkinson's disease: beyond neuronal function. FEBS Open Bio. 2023;13(9):1558-1579. doi:10.1002/2211-5463.13651
BibTeX
@article{Spanos2023,
author = {Spanos, Fokion and Deleidi, Michela},
title = {Glycolipids in Parkinson's disease: beyond neuronal function},
journal = {FEBS Open Bio},
year = {2023},
volume = {13},
number = {9},
pages = {1558--1579},
doi = {10.1002/2211-5463.13651}
}
EUVIMED